The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient

被引:31
|
作者
Gopalakrishna, Ajay [1 ]
Longo, Thomas A. [1 ]
Fantony, Joseph J. [1 ]
Owusu, Richmond [2 ]
Foo, Wen-Chi [3 ]
Dash, Rajesh [3 ]
Inman, Brant A. [1 ]
机构
[1] Duke Univ, Med Ctr, Div Urol, Durham, NC 27710 USA
[2] Univ Calif San Diego, Dept Urol, San Diego, CA 92103 USA
[3] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
来源
BMC UROLOGY | 2016年 / 16卷
基金
美国国家卫生研究院;
关键词
FISH; Cytology; Bladder cancer; Sensitivity; Specificity; Spectrum effects; SPECTRUM BIAS; CARCINOMA; INTEROBSERVER; EXPRESSION; GUIDELINES; MANAGEMENT; CYTOLOGY; GENDER; STAGE;
D O I
10.1186/s12894-016-0147-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Spectrum effects refer to the phenomenon that test performance varies across subgroups of a population. When spectrum effects occur during diagnostic testing for cancer, difficult patient misdiagnoses can occur. Our objective was to evaluate the effect of test indication, age, gender, race, and smoking status on the performance characteristics of two commonly used diagnostic tests for bladder cancer, urine cytology and fluorescence in situ hybridization (FISH). Methods: We assessed all subjects who underwent cystoscopy, cytology, and FISH at our institution from 2003 to 2012. The standard diagnostic test performance metrics were calculated using marginal models to account for clustered/repeated measures within subjects. We calculated test performance for the overall cohort by test indication as well as by key patient variables: age, gender, race, and smoking status. Results: A total of 4023 cystoscopy-cytology pairs and 1696 FISH-cystoscopy pairs were included in the analysis. In both FISH and cytology, increasing age, male gender, and history of smoking were associated with increased sensitivity and decreased specificity. FISH performance was most impacted by age, with an increase in sensitivity from 17 % at age 40 to 49 % at age 80. The same was true of cytology, with an increase in sensitivity from 50 % at age 40 to 67 % at age 80. Sensitivity of FISH was higher for a previous diagnosis of bladder cancer (46 %) than for hematuria (26 %). Test indication had no impact on the performance of cytology and race had no significant impact on the performance of either test. Conclusions: The diagnostic performance of urine cytology and FISH vary significantly according to the patient demographic in which they were tested. Hence, the reporting of spectrum effects in diagnostic tests should become part of standard practice. Patient-related factors must contextualize the clinicians' interpretation of test results and their decision-making.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Epidemiology, diagnosis and urine-based investigation techniques in bladder cancer
    Hakenberg, O. W.
    [J]. ONKOLOGE, 2007, 13 (12): : 1067 - +
  • [22] AN AUDIT OF DIAGNOSTIC ACCURACY OF URINE CYTOLOGY IN BLADDER CANCER
    Singh, M.
    Salman, W.
    [J]. ACTA CYTOLOGICA, 2010, 54 (03) : 521 - 521
  • [23] Diagnostic accuracy of urine-based kits for detection of Helicobacter pylori antibody in children
    Okuda, Masumi
    Kamiya, Shigeru
    Booka, Mina
    Kikuchi, Shogo
    Osaki, Takako
    Hiwatani, Tomoko
    Maekawa, Kohei
    Fukuda, Yoshihiro
    [J]. PEDIATRICS INTERNATIONAL, 2013, 55 (03) : 337 - 341
  • [24] Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral Population
    Cuzick, Jack
    Cadman, Louise
    Ahmad, Amar S.
    Ho, Linda
    Terry, George
    Kleeman, Michelle
    Lyons, Deirdre
    Austin, Janet
    Stoler, Mark H.
    Vibat, Cecile Rose T.
    Dockter, Janel
    Robbins, David
    Billings, Paul R.
    Erlander, Mark G.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (07) : 1053 - 1059
  • [25] Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature
    Zhang, Ge
    Gomes-Giacoia, Evan
    Dai, Yunfeng
    Lawton, Adrienne
    Miyake, Makito
    Furuya, Hideki
    Goodison, Steve
    Rosser, Charles J.
    [J]. DIAGNOSTIC PATHOLOGY, 2014, 9 : 200
  • [26] Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature
    Ge Zhang
    Evan Gomes-Giacoia
    Yunfeng Dai
    Adrienne Lawton
    Makito Miyake
    Hideki Furuya
    Steve Goodison
    Charles J Rosser
    [J]. Diagnostic Pathology, 9
  • [27] A novel, robust multiplex urine-based immunoassay for bladder cancer detection
    Furuya, Hideki
    Dai, Yunfeng
    Hokutan, Kanani
    Lotan, Yair
    Rosser, Charles Joel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] A novel, robust multiplex urine-based immunoassay for bladder cancer detection
    Rosser, Charles Joel
    Furuya, Hideki
    Hokutan, Kanani
    Dai, Yunfeng
    Lotan, Yair
    Thornquist, Mark
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 148 - 148
  • [29] Bladder cancer screening and future directions in urine-based markers for bladder urothelial carcinoma
    Karam, Jose A.
    Lotan, Yair
    Shariat, Shahrokh E.
    [J]. LABMEDICINE, 2007, 38 (02): : 116 - 120
  • [30] COMBINATION OF TWO NON INVASIVE URINE TESTS (TRAP AND FISH) GREATLY INCREASES ACCURACY IN DIAGNOSING BLADDER CANCER IN SYMPTOMATIC PATIENTS
    Bravaccini, S.
    Casadio, V.
    Amadori, D.
    Zoli, W.
    Gunelli, R.
    Nanni, O.
    Silvestrini, R.
    Calistri, D.
    [J]. CELLULAR ONCOLOGY, 2010, 32 (03) : 200 - 200